Our previous studies showed that TC-PTP deficiency in mouse keratinocytes confers resistance to tumor initiator 7,12-dimethylbenz[a]anthracene (DMBA)-induced apoptosis accompanied by increased expression of phosphorylated AKT. This evidence concerns the gene PTPN2 and neoplasm.